Eye-tracking evidence that happy faces impair verbal message comprehension: the case of health warnings in direct-to-consumer pharmaceutical television commercials
Abstract:Risk warning or disclosure information in advertising is only effective in correcting consumers’ judgments if enough cognitive capacity is available to process that information. Hence, comprehension of verbal warnings in TV commercials may suffer if accompanied by positive visual elements. This research addresses this concern about cross-modality interference in the context of direct-to-consumer (DTC) pharmaceutical commercials in the United States by experimentally testing whether positive facial expressions … Show more
“…However, these researchers also found that the presence of distraction did not reduce overall consumer perceptions of risk. In a second eye-tracking study of DTCA, Russell et al (2017) reported that message comprehension was impaired by an increased frequency of positive facial expressions during the major statement.…”
Section: Research On Distraction In Dtcamentioning
confidence: 99%
“…Of concern is the possibility that the positive affect arising from visual imagery may reduce risk perceptions (Finucane et al 2000; Slovic et al 2007). Prior research using small samples of DTCA found that the presence of positive imagery during the major statement can also inhibit message comprehension (Russell et al 2017). Pairing incongruent audio and visual information has been characterized as a form of distraction (Penney 1989).…”
Direct-to-consumer advertising (DTCA) on television is a prominent source of information about medical conditions and their potential treatments. In the United States, the Food and Drug Administration (FDA) requires that DTCA include a major statement presenting the medication’s most important risk information in a fair and balanced manner. However, there is growing concern about the visual content that accompanies this risk information within DTCA major statements. Specifically, the FDA has failed to provide guidance on how to measure DTCA’s adherence to the fair and balanced provision. This research introduces eight metrics organized into three categories to perform a visual content analysis of 230 existing DTCAs. Using these metrics, the authors test for differences in visual content between the major risk statement and the remaining portions of an ad. Our results indicate that the major risk statements of DTCAs feature more positive imagery, visually complex imagery, and motion than other portions of the ads. The authors discuss the implications of these findings for public policy makers, consumers, and marketers.
“…However, these researchers also found that the presence of distraction did not reduce overall consumer perceptions of risk. In a second eye-tracking study of DTCA, Russell et al (2017) reported that message comprehension was impaired by an increased frequency of positive facial expressions during the major statement.…”
Section: Research On Distraction In Dtcamentioning
confidence: 99%
“…Of concern is the possibility that the positive affect arising from visual imagery may reduce risk perceptions (Finucane et al 2000; Slovic et al 2007). Prior research using small samples of DTCA found that the presence of positive imagery during the major statement can also inhibit message comprehension (Russell et al 2017). Pairing incongruent audio and visual information has been characterized as a form of distraction (Penney 1989).…”
Direct-to-consumer advertising (DTCA) on television is a prominent source of information about medical conditions and their potential treatments. In the United States, the Food and Drug Administration (FDA) requires that DTCA include a major statement presenting the medication’s most important risk information in a fair and balanced manner. However, there is growing concern about the visual content that accompanies this risk information within DTCA major statements. Specifically, the FDA has failed to provide guidance on how to measure DTCA’s adherence to the fair and balanced provision. This research introduces eight metrics organized into three categories to perform a visual content analysis of 230 existing DTCAs. Using these metrics, the authors test for differences in visual content between the major risk statement and the remaining portions of an ad. Our results indicate that the major risk statements of DTCAs feature more positive imagery, visually complex imagery, and motion than other portions of the ads. The authors discuss the implications of these findings for public policy makers, consumers, and marketers.
“…Next, a recognition memory test was adapted, as utilized in a study of verbal message comprehension in DTC prescription drug commercials (Russell et al ) as well as a study on the impact of efficacy information on the recollection of benefits and risks for a DTC cholesterol drug commercial (O'Donoghue et al ). In this task, participants are presented with a list of 20 risks (or benefits, depending on the condition to which they were exposed) from the original list created by the focus group, and asked to select the four items they heard within the viewed clip.…”
Section: Methodsmentioning
confidence: 99%
“…Consumer advocates worry that as health literacy decreases, consumers will become more reliant on other cognitive heuristics, such as animation, resulting in less well‐informed health‐related decision making and suboptimal medical outcomes. For example, in a study of health warnings within DTC prescription drug advertisements, eye‐tracking data suggest interference between positive visual elements and risk warning comprehension (Russell et al ). In 2016, the FDA announced its interest in better understanding the impact of visual effects such as superimposed text and animated characters on consumer perception of drug advertisements, noting concern that animation “may interfere with message communication” (McCaffry ).…”
The Food and Drug Administration (FDA) has noted that animation within direct‐to‐consumer (DTC) pharmaceutical advertising may impact perceptions of risk or benefit, and that there have been few if any comprehensives studies of the impact animation may exert upon consumers. This article proposes that the use of animation in pharmaceutical advertising potentially disrupts the encoding process in the mind of the consumer, impacting perceptions of prescription drug benefits and risks. Using novel stimuli employing a rotoscoping technique, it is found that animation significantly reduces perceptions of perceived risk (but not benefits), and that this effect is driven by disruptions in encoding (Study 1). These findings are extended to examine deeper consumer inferences (Study 2). Implications for the pharmaceutical industry, consumer protection agencies, and consumers are considered.
“…That has grabbed immense attention from both academia and industrial field, and collaboration between marketers, neuroscientists, and psychologists in order to better understand what drives consumer behavior and neural processing of advertising in the human brain [60]. For example, it has divided neuroimaging tools that provide evidence on neural correlates of advertising and consumers' behavior into two categories, as follows: (1) recording electrical activity signals such as electroencephalography (EEG) and magnetoencephalography (MEG), and (2) recording metabolic activity signals such as functional magnetic resonance imaging (fMRI) and functional near-infrared spectroscopy (fNIRS) [13,[61][62][63][64][65].…”
Section: An Overview Of Neuroimaging Tools Used In Advertising Researchmentioning
Despite the advancement in neuroimaging tools, studies about using neuroimaging tools to study the impact of advertising on brain regions and processes are scant and remain unclear in academic literature. In this article, we have followed a literature review methodology and a bibliometric analysis to select empirical and review papers that employed neuroimaging tools in advertising campaigns and to understand the global research trends in the neuromarketing domain. We extracted and analyzed sixty-three articles from the Web of Science database to answer our study questions. We found four common neuroimaging techniques employed in advertising research. We also found that the orbitofrontal cortex (OFC), the ventromedial prefrontal cortex, and the dorsolateral prefrontal cortex play a vital role in decision-making processes. The OFC is linked to positive valence, and the lateral OFC and left dorsal anterior insula related in negative valence. In addition, the thalamus and primary visual area associated with the bottom-up attention system, whereas the top-down attention system connected to the dorsolateral prefrontal cortex, parietal cortex, and primary visual areas. For memory, the hippocampus is responsible for generating and processing memories. We hope that this study provides valuable insights about the main brain regions and processes of interest for advertising.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.